IBDEI0RJ ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,12396,1,3,0)
 ;;=3^HIV Counseling
 ;;^UTILITY(U,$J,358.3,12396,1,4,0)
 ;;=4^Z71.7
 ;;^UTILITY(U,$J,358.3,12396,2)
 ;;=^5063251
 ;;^UTILITY(U,$J,358.3,12397,0)
 ;;=Z76.89^^49^599^5
 ;;^UTILITY(U,$J,358.3,12397,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12397,1,3,0)
 ;;=3^Persons Encountering Health Services for Oth Circumstances
 ;;^UTILITY(U,$J,358.3,12397,1,4,0)
 ;;=4^Z76.89
 ;;^UTILITY(U,$J,358.3,12397,2)
 ;;=^5063304
 ;;^UTILITY(U,$J,358.3,12398,0)
 ;;=Z01.812^^49^599^3
 ;;^UTILITY(U,$J,358.3,12398,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12398,1,3,0)
 ;;=3^Lab Result Counseling
 ;;^UTILITY(U,$J,358.3,12398,1,4,0)
 ;;=4^Z01.812
 ;;^UTILITY(U,$J,358.3,12398,2)
 ;;=^5062627
 ;;^UTILITY(U,$J,358.3,12399,0)
 ;;=Z11.7^^49^599^6
 ;;^UTILITY(U,$J,358.3,12399,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12399,1,3,0)
 ;;=3^Testing for Latent Tuberculosis Infection
 ;;^UTILITY(U,$J,358.3,12399,1,4,0)
 ;;=4^Z11.7
 ;;^UTILITY(U,$J,358.3,12399,2)
 ;;=^5158320
 ;;^UTILITY(U,$J,358.3,12400,0)
 ;;=Z22.7^^49^599^4
 ;;^UTILITY(U,$J,358.3,12400,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12400,1,3,0)
 ;;=3^Latent Tuberculosis
 ;;^UTILITY(U,$J,358.3,12400,1,4,0)
 ;;=4^Z22.7
 ;;^UTILITY(U,$J,358.3,12400,2)
 ;;=^5158321
 ;;^UTILITY(U,$J,358.3,12401,0)
 ;;=E03.9^^49^600^29
 ;;^UTILITY(U,$J,358.3,12401,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12401,1,3,0)
 ;;=3^Hypothroidism,Unspec
 ;;^UTILITY(U,$J,358.3,12401,1,4,0)
 ;;=4^E03.9
 ;;^UTILITY(U,$J,358.3,12401,2)
 ;;=^5002476
 ;;^UTILITY(U,$J,358.3,12402,0)
 ;;=E11.9^^49^600^23
 ;;^UTILITY(U,$J,358.3,12402,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12402,1,3,0)
 ;;=3^DM Type 2 w/o Complications
 ;;^UTILITY(U,$J,358.3,12402,1,4,0)
 ;;=4^E11.9
 ;;^UTILITY(U,$J,358.3,12402,2)
 ;;=^5002666
 ;;^UTILITY(U,$J,358.3,12403,0)
 ;;=E10.9^^49^600^7
 ;;^UTILITY(U,$J,358.3,12403,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12403,1,3,0)
 ;;=3^DM Type 1 w/o Complications
 ;;^UTILITY(U,$J,358.3,12403,1,4,0)
 ;;=4^E10.9
 ;;^UTILITY(U,$J,358.3,12403,2)
 ;;=^5002626
 ;;^UTILITY(U,$J,358.3,12404,0)
 ;;=E11.65^^49^600^16
 ;;^UTILITY(U,$J,358.3,12404,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12404,1,3,0)
 ;;=3^DM Type 2 w/ Hyperglycemia
 ;;^UTILITY(U,$J,358.3,12404,1,4,0)
 ;;=4^E11.65
 ;;^UTILITY(U,$J,358.3,12404,2)
 ;;=^5002663
 ;;^UTILITY(U,$J,358.3,12405,0)
 ;;=E53.8^^49^600^34
 ;;^UTILITY(U,$J,358.3,12405,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12405,1,3,0)
 ;;=3^Vitamin B Deficiency NEC
 ;;^UTILITY(U,$J,358.3,12405,1,4,0)
 ;;=4^E53.8
 ;;^UTILITY(U,$J,358.3,12405,2)
 ;;=^5002797
 ;;^UTILITY(U,$J,358.3,12406,0)
 ;;=E78.5^^49^600^27
 ;;^UTILITY(U,$J,358.3,12406,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12406,1,3,0)
 ;;=3^Hyperlipidemia,Unspec
 ;;^UTILITY(U,$J,358.3,12406,1,4,0)
 ;;=4^E78.5
 ;;^UTILITY(U,$J,358.3,12406,2)
 ;;=^5002969
 ;;^UTILITY(U,$J,358.3,12407,0)
 ;;=E66.01^^49^600^31
 ;;^UTILITY(U,$J,358.3,12407,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12407,1,3,0)
 ;;=3^Morbid Obesity
 ;;^UTILITY(U,$J,358.3,12407,1,4,0)
 ;;=4^E66.01
 ;;^UTILITY(U,$J,358.3,12407,2)
 ;;=^5002826
 ;;^UTILITY(U,$J,358.3,12408,0)
 ;;=D64.9^^49^600^6
 ;;^UTILITY(U,$J,358.3,12408,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12408,1,3,0)
 ;;=3^Anemia,Unspec
 ;;^UTILITY(U,$J,358.3,12408,1,4,0)
 ;;=4^D64.9
 ;;^UTILITY(U,$J,358.3,12408,2)
 ;;=^5002351
 ;;^UTILITY(U,$J,358.3,12409,0)
 ;;=D68.318^^49^600^25
